Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Revenue

Novelix Pharmaceuticals had revenue of 369.15M INR in the quarter ending June 30, 2026, with 65.16% growth. This brings the company's total for the last twelve months to 1.47B, up 180.42% year-over-year. In the fiscal year ending March 31, 2026, Novelix Pharmaceuticals had annual revenue of 1.32B with 330.60% growth. That makes Novelix Pharmaceuticals the 35,251st largest company in the world by revenue and 2,826th in India.

• Revenue (ttm): 1.47B
• Revenue Growth: +180.42%
• P/S Ratio: 1.16
• Revenue / Employee: 45.91M
• Employees: 32
• Market Cap: 1.71B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharma Business 295.09M 96.0%
• Trading in Shares 12.09M 3.9%
• Finance 159.58K 0.1%

Fiscal year ended Mar 31, 2025 See the full Novelix Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.32B	1.02B	330.60%
Mar 31, 2025	307.33M	262.02M	578.26%
Mar 31, 2024	45.31M	26.11M	135.96%
Mar 31, 2023	19.20M	-69.92M	-78.45%
Mar 31, 2022	89.13M	-6.72M	-7.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error